Abstract
The infertility of many couples seems to rest on an enigmatic dysfunction of the men’s sperm, rendering early diagnosis and evidence-based treatment by medically assisted reproduction impossible. Using a novel laboratory test, we assessed the function of the flagellar Ca2+ channel CatSper in sperm of almost 2,300 men undergoing a fertility workup. Thereby, we identified a group of men with mutations in CATSPER genes affecting the function of the channel. Although standard semen and computer-assisted sperm analysis were unremarkable, the couples required intracytoplasmic sperm injection (ICSI) to conceive a child. We show that their seemingly unexplained infertility and need for ICSI is, in fact, due to the failure of CatSper-deficient human sperm to hyperactivate and penetrate the egg coat. In summary, our study reveals that defective CatSper function represents the most common cause of unexplained male-factor infertility known thus far and that CatSper-related infertility can readily be diagnosed, enabling evidence-based treatment.
Introduction
Infertility is a multifactorial disease affecting about 50 million couples worldwide; in half of the cases, a male factor contributes to or is solely responsible for the failure to conceive (Agarwal et al., 2015). Male-factor infertility is often attributed to an insufficient sperm count (oligo-, crypto-, or azoospermia), impaired sperm motility (asthenozoospermia), and/or abnormal sperm morphology (teratozoospermia). However, for about one third of infertile men, semen parameters are within reference limits (normozoospermia) (Tüttelmann et al., 2018). This so called ‘unexplained male infertility’ seems to rest on elusive functional defects of the sperm that are undetectable by standard semen analysis. Moreover, if the fertility workup of the female partner is also unremarkable, affected couples present with ‘unexplained couple infertility’, precluding early diagnosis of the infertility and evidence-based treatment by medically assisted reproduction (MAR) (Barratt et al., 2011). As a result, affected couples experience failed MAR attempts, which is not only time consuming and costly, but exposes primarily the female partner to medical risks.
Most sperm functions, e.g., the swimming behavior and acrosomal exocytosis (Alvarez et al., 2014; Publicover et al., 2008), are controlled by changes in the intracellular Ca2+ concentration ([Ca2+]i). In many species including mammals, [Ca2+]i is controlled by the sperm-specific voltage- and alkaline-activated Ca2+ channel CatSper (Brown et al., 2019; Lishko & Kirichok, 2010; Loux et al., 2013; Navarro et al., 2008; Quill et al., 2001; Rahban & Nef, 2020; Ren et al., 2001; Seifert et al., 2015; Wang et al., 2021a). Mammalian CatSper comprises four homologous pore-forming subunits (CatSper 1-4) (Lin et al., 2021; Navarro et al., 2008; Wang et al., 2021a) and a large number of auxiliary subunits (CatSper β, γ, δ, ɛ, ζ, η, τ, Trim69, Slco6c1, Efcab9, Tmem249 and, perhaps, Cdc42) (Chung et al., 2011, 2017; Hwang et al., 2019, 2022; Lin et al., 2021; Liu et al., 2007; Luque et al., 2021; Wang et al., 2009) for gene/protein nomenclature, see Supplementary Table 1. In mice, targeted ablation of genes encoding CatSper subunits leads to defective channel function, but does not affect sperm number, morphology, or basal motility (Carlson et al., 2003, 2005; Chung et al., 2011, 2017; Liu et al., 2007; Qi et al., 2007; Quill et al., 2001; Wang et al., 2009; Zeng et al., 2013). Yet, mouse sperm lacking functional CatSper are unable to switch to so-called hyperactivated motility (Carlson et al., 2003; Chung et al., 2011, 2014; Ho et al., 2009; Jin et al., 2007; Qi et al., 2007; Quill et al., 2003) and, therefore, fail to traverse the oviduct and penetrate the egg coat (Ho et al., 2009; Jin et al., 2007; Ren et al., 2001), resulting in male infertility (reviewed by Wang et al., 2021a). Similarly, impaired rather than total loss of CatSper function also affects hyperactivation, resulting in sub- or infertile male mice (Chung et al., 2017; Hwang et al., 2019, 2022).
These results in mice prompted studies on the role of CatSper in human infertility. Indeed, genetic analysis of consanguineous families with clustering of male-factor infertility identified several men with nonsense variants and homozygous deletions of the CATSPER1 or CATSPER2 genes, respectively (Avenarius et al., 2009; Avidan et al., 2003; Hildebrand et al., 2010; Smith et al., 2013; Zhang et al., 2007). Surprisingly, these men were reported as (oligo)asthenoteratozoospermic, suggesting that in humans, as opposed to mice, CatSper is required for proper sperm production. Of note, in the men lacking CATSPER2, the contiguous STRC gene encoding stereocilin was also homozygously deleted, which causes mild-to-moderate hearing loss (Verpy et al., 2001; Vona et al., 2015; Yokota et al., 2019). The contiguous deletion of CATSPER2 and STRC was, thus, termed ‘deafness-infertility syndrome’, DIS (OMIM #611102) (Zhang et al., 2007).
More recently, the concept that CatSper is required for human spermatogenesis has been challenged by the identification of three men with variants in variants in CATSPERE (Brown et al., 2018; Williams et al., 2015), CATSPER2 (Luo et al., 2019), or CATSPER3 (Wang et al., 2021b), causing loss of channel function. These men were also infertile, but normozoospermic, indicative of defective function rather than production of sperm. Supporting this notion, their sperm also failed to fertilize the egg upon in vitro fertilization (IVF), whereas ICSI was successful. Analysis of the phenotype of CatSper-deficient sperm from these three men yielded, however, partly conflicting results or was rather incomplete: For example, hyperactivated sperm motility was abolished (Luo et al., 2019), seemingly unaffected (Williams et al., 2015), or not even assessed (Wang et al., 2021b).
To summarize, despite the discovery of CatSper more than two decades ago, systematic studies on CatSper-deficient men are lacking and results on the reproductive phenotype of those few men identified are conflicting. Accordingly, the role of CatSper in spermatogenesis, sperm function, and infertility in humans has remained ill-defined and controversial.
To solve these long-standing questions, we systematically assessed the function of CatSper in sperm of men undergoing a fertility workup, using a simple motility-based ‘CatSper-Activity-Test’. Thereby, we identified eight men with loss of CatSper function homozygously deleted for CATSPER2 and one man with impaired channel function featuring bi-allelic variants of CATSPERE. CatSper-deficient men presented with unexplained couple infertility involving failure of MAR via ovulation induction (OI), intrauterine insemination (IUI), and/or IVF. By comprehensive microfluidics- and optochemistry-aided motility and flagellar-beat analyses, we revealed the functional deficits of CatSper-deficient human sperm underlying the infertility, failure of OI/IUI/IVF, and need of ICSI. Altogether, we demonstrate that defective CatSper function leads to a similar infertility phenotype in mice and men. Moreover, with an estimated prevalence of about 2.3%, it represents the most common male factor underlying unexplained couple infertility know thus far. Finally, we show that a simple motility-based test can serve as a tool for diagnosis of CatSper-related infertility and evidence-based selection of the technique for medically assisted reproduction.
Materials and Methods
Study subjects and ethical approval
The study involved men that underwent semen analysis according to WHO standard procedures (WHO 2010) at the Department of Clinical and Surgical Andrology of the Centre of Reproductive Medicine and Andrology, Münster, as well as healthy volunteers (donors). Clinical data routinely documented in our clinical database Androbase (Tüttelmann et al., 2006) were used for patient phenotyping (see Table 1 and Supplementary Fig. 4). All participants gave written informed consent according to the protocols approved by the Ethics Committee of the Ärztekammer Westfalen-Lippe and the Medical Faculty Münster (4INie, 2021-402-f-S, and 2010-578-f-S) and according to the Declaration of Helsinki. Genetic analyses were performed within the Male Reproductive Genomics (MERGE) study (Wyrwoll et al., 2020). The MERGE subject IDs of the CATSPER2 and CATSPERE patients are: C1 = M1, C2 = M1B1, C3 = M1755, C4 = M1782, C5 = M2107, C6 = M2157, C7 = M2108, C8 = M2212, C9 = M2439.
Reagents
Chemicals were purchased from AppliChem (Darmstadt, Germany), Carl Roth (Karlsruhe, Germany), Cayman Chemical (Ann Arbor, USA), Fisher Scientific (Schwerte, Germany), Honeywell Fluka (Charlotte, USA), Sigma-Aldrich (Steinheim, Germany), ThermoFischer Scientific (Waltham, USA), and Tocris Bioscience (Bristol, UK). Human serum albumin (HSA) was purchased from Irvine Scientific (Santa Ana, USA).
Sperm preparation and buffer conditions
Semen samples provided by donors and patients for research purposes were produced by masturbation and ejaculated into plastic containers. Ejaculates were allowed to liquefy at 37 °C for 30–60 min. Motile sperm were isolated from the ejaculates by a “swim-up” procedure: In a 50-ml conical centrifuge tube, aliquots of 0.5–1 ml ejaculate were layered under 4 ml of human tubal fluid (HTF) buffer containing (in mM): 97.8 NaCl, 4.69 KCl, 0.2 MgSO4, 0.37 KH2PO4, 2.04 CaCl2, 0.33 Na-pyruvate, 21.4 lactic acid, 2.78 glucose, 21 HEPES, and 4 NaHCO3; adjusted between pH 7.3–7.4 with NaOH. Alternatively, the liquefied semen was diluted 1:10 with HTF, and sperm, somatic cells, and cell debris were pelleted by centrifugation (700 x g, 20 min, 37 °C). The sediment was then resuspended in the same volume of HTF in 50-ml centrifuge tubes. Aliquots of 5 ml of this suspension were pelleted in the 50-ml tubes using a centrifuge with a fixed-angle rotor (700 x g, 5 min, room temperature). In both cases, motile sperm were allowed to swim out of the sediment for at least 60 minutes at 37 °C, collected with the supernatant, and washed twice with HTF (700 x g, 20 min, 37 °C). After the second centrifugation, sperm were resuspended in HTF supplemented with 3 mg/ml HSA (dubbed HTF+), or in capacitating HTF++ containing (in mM): 72.8 NaCl, 4.69 KCl, 0.2 MgSO4, 0.37 KH2PO4, 2.04 CaCl2, 0.33 Na-pyruvate, 21.4 lactic acid, 2.78 glucose, 25 NaHCO3, and 21 HEPES, pH 7.35 (adjusted with NaOH), and supplemented with 3 mg/ml HSA. The sperm density was determined using a Neubauer counting chamber and adjusted to 1 x 107 sperm/ml. Sperm were incubated at 37 °C under capacitating conditions in HTF++ for at least 2 and 3 h for acrosome-reaction assays and motility analysis, respectively.
For motility experiments designed to study non-capacitated and capacitated sperm side-by-side, an aliquot of the ejaculate of donors or CATSPER2-/-patients was subjected to swim-up and ensuing washing procedures in bicarbonate-free HTF (HTF0BC) containing (in mM): 97.8 NaCl, 4.69 KCl, 0.2 MgSO4, 0.37 KH2PO4, 2.04 CaCl2, 0.33 Na-pyruvate, 21.4 lactic acid, 2.78 glucose, and 21 HEPES, pH 7.35 (adjusted with NaOH) without HSA, representing non-capacitating conditions.
Analysis of sperm-motility decay in Ca2+-free buffer
Swim-up sperm in HTF+ were diluted tenfold in HTF+ or Ca2+-free HTF (HTF0Ca; [Ca2+]o < 20 nM), containing (in mM): 91.8 NaCl, 4.69 KCl, 0.2 MgSO4, 0.37 KH2PO4, 5 EGTA, 0.33 Na-pyruvate, 21.4 lactic acid, 2.78 glucose, 25 NaHCO3, and 21 HEPES, adjusted to pH 7.35 with NaOH, supplemented with 3 mg/ml HSA. The fraction of motile sperm was monitored over time. The time constant, τ, of the motility decay of sperm in HTF0Ca was derived by nonlinear regression analysis using the one-phase decay equation: Y = (Y0 − plateau) ∗ e(−X·(1/τ)) + plateau, where Y is the fraction of motile cells (%), Y0 is the initial fraction of motile cells (constrained to 100%), Plateau is the fraction of motile cells at infinite time (constrained to 0%), and x is the time. To study the role of CatSper in the HTF0Ca-induced motility decay, the buffer was fortified with progesterone or RU1968.
CatSper-Activity-Test
The CatSper-Activity-Test was performed on men undergoing a standard semen analysis in the course of a fertility workup at our centre, provided that the ejaculate featured a total sperm count ≥ 5 × 106 cells and ≥ 10% total motile sperm. We also performed the test on ejaculates from donors. A 20-µl aliquot of the ejaculate was diluted tenfold in HTF+ (Buffer A) and HTF0Ca containing 10 µM progesterone (Buffer B) or Buffer B including 5 mM EDTA. To derive the “CatSper-Activity-Index” (CAI), the fraction of motile sperm in Buffer A and Buffer B was determined after 15 or 30 minutes and in Buffer B including EDTA after 30 or 60 minutes according to the following equation: 
.
Measurement of changes in [Ca2+]i in sperm populations
Changes in [Ca2+]i were measured in swim-up sperm (in HTF+) loaded with the fluorescent Ca2+ indicator Fluo-4-AM in 384 multi-well plates in a fluorescence plate reader (Fluostar Omega, BMG Labtech; Ortenberg, Germany) at 30 °C as described before (Brenker, et al., 2018a; Schiffer et al., 2014; Strünker et al., 2011). Briefly, sperm were loaded with Fluo-4-AM (5 µM, 20 min) at 37 °C in the presence of Pluronic F-127 (0.05% w/v). After incubation, excess dye was removed by centrifugation (700 x g, 5 min, room temperature). Sperm were resuspended in HTF at a density of 5 × 106 cells/ml. Each well was filled with 54 µl of the sperm suspension; the fluorophore was excited at 480 nm (Fluo-4), and fluorescence emission was recorded at 520 nm. Changes in Fluo-4 fluorescence were converted to changes in ΔF/F0 (%), indicating the percentage change in fluorescence (ΔF) with respect to the mean basal fluorescence (F0) before application of buffer or stimuli, respectively. The changes in ΔF/F0 (%) evoked by progesterone, PGE1, or NH4Cl were normalized to the maximal increase in ΔF/F0 (%) evoked by ionomycin to correct for inter-experimental variations in maximal signal amplitudes.
Single-cell Ca2 fluorimetry
Slides (10-well CELLview slide, Greiner Bio-One; Frickenhausen, Germany) were prepared by coating the wells with poly-L-lysine by incubating the empty wells for 60 min at 37 °C in a 1:10 aqueous mixture of poly-L-lysine solution (1 mg/ml) and sodium borate buffer (1 M, pH 8.5). Treated wells were washed with HTF+ buffer and left to dry. Swim-up sperm in HTF+ were loaded with Fluo-4-AM (5 µM, 60 min) at 37 °C in the presence of Pluronic F-127 (0.05% w/v). After incubation, excess dye was removed by centrifugation (700 x g, 5 min, room temperature). Sperm pellets were resuspended in HTF+ to a density of 5 × 106 cells/ml, aliquoted (200 µl) into the prepared wells, and placed in an incubator (37 °C, 10% CO2) for one hour to allow sperm to settle. Wells were then washed with HTF+ and placed under an inverted microscope (IX73, Olympus; Hamburg, Germany) with a condenser (IX2-LWUCD, Olympus; Hamburg, Germany) and a custom-made dark-field filter, housed in an incubator with circulating air heated to 37 °C, and equipped with a 20× objective (UPLFLN20XPH, Olympus; Hamburg, Germany). Wells were illuminated with an LED (475/35 nm, Thorlabs; Lübeck, Germany) and image sequences were recorded at one frame per second (fps) for up to an hour using the sCMOS camera (Zyla 4.2 Plus, Andor Technology; Belfast, UK). After obtaining a fluorescence baseline, either 22 µl of progesterone (3 µM final) or HTF+ (control) was added to the well followed by 24.4 µl of ionomycin (1 µM final) as a positive control. Image sequences were analyzed using ImageJ (NIH; Bethesda, USA) and the change in fluorescence intensity (ΔF/F0) of selected cells was normalized to the corresponding ionomycin signal.
Electrophysiology
We recorded from swim-up sperm in the whole-cell configuration as described before (Strünker et al., 2011). Seals between pipette and sperm were formed either at the cytoplasmic droplet or in the neck region in standard extracellular solution (HS) containing (in mM): 135 NaCl, 5 KCl, 1 MgSO4, 2 CaCl2, 5 glucose, 1 Na-pyruvate, 10 lactic acid, and 20 HEPES, adjusted to pH 7.4 with NaOH. Monovalent currents were recorded in a sodium-based divalent-free solution (NaDVF) containing (in mM): 140 NaCl, 40 HEPES, and 1 EGTA, adjusted to pH 7.4 with NaOH; the pipette (10–15 MΩ) solution contained (in mM): 130 Cs-aspartate, 5 CsCl, 50 HEPES, and 5 EGTA, adjusted to pH 7.3 with CsOH. Data were not corrected for liquid junction potentials.
Genetics Analyses
Genomic DNA was extracted via local standard methods from peripheral blood or buccal swabs obtained from the patients/family members.
Single nucleotide-polymorphism (SNP) array
Genetic workup started with SNP-array analysis using the Infinium CytoSNP-850K v1.2 BeadChip Kit (Illumina; San Diego, USA) according to the manufacturer’s protocol. The BeadChips were scanned using the NextSeq 550 System (Illumina; San Diego, USA). Data was analyzed with BlueFuse Multi v4.5 (Illumina; San Diego, USA).
Multiple ligation-dependent probe amplification (MLPA)
To determine the extent of the deletions on chromosome 15 identified in patients C1-C8 via the SNP array, the SALSA MLPA Probemix P461-A1 DIS (MRC Holland; Amsterdam, The Netherlands) kit was used. This MLPA is designed to analyze subjects with sensorineural hearing loss and, therefore, specifically detects deletions or duplications in the genes STRC, CATSPER2 and OTOA. Data was analyzed with Coffalyser.Net analysis software (MRC Holland; Amsterdam, The Netherlands).
Exome sequencing and analysis
Because patient C9 did not feature a deletion of CATSPER2, we sequenced his exome. After enrichment with Twist Bioscience’s Human Core Exome kit, sequencing was conducted on the Illumina NovaSeq 6000® system using the TruSeq SBS Kit v3 - HS (200 cycles). The bioinformatic analyses have been described in detail elsewhere (Wyrwoll et al., 2022). In brief, trimming and alignment of reads (Cutadapt v1.18, BWA Mem v0.7.17) and subsequent calling and annotation of variants (GATK toolkit v3.8, Ensembl Variant Effect Predictor v100) were carried out. Exome data were screened focusing on rare (minor allele frequency [MAF] <1% in the gnomAD database, v2.1.1) bi-allelic variants predicted to affect protein function (stop-gain, frameshift, and splice site variants as well as missense variants with a Combined Annotation Dependent Depletion [CADD] score ≥ 20) in genes encoding subunits or regulatory proteins of the CatSper channel (Supplementary Table 1).
Sanger sequencing. Validation of variants in C9 and segregation analysis in family members were performed by Sanger sequencing. Primer sequences are provided in Supplementary Table 2.
Standard computer-assisted sperm analysis (CASA)
Custom motility chambers (depth ∼60 µm) were prepared by applying two pieces of adhesive tape to a glass slide approximately one centimeter apart. Samples (30 µl) of diluted ejaculates or swim-up sperm were then placed between the strips of adhesive tape and the assembly covered with a coverslip. For basal motility analysis, dark-field images of ejaculates diluted 1:10 in HTF+ were recorded with a CMOS camera (UI-3140CP-M-GL R2, iDS GmbH; Obersulm, Germany) at 80 fps for 1 sec with an upright microscope (BX-40, Olympus; Hamburg, Germany) equipped with a heated (37°C) stage (HT 50, Minitüb; Tiefenbach, Germany) and a 10× objective (UPLANFL 10X, Olympus; Hamburg, Germany), and a 0.5× magnification adapter (U-TV0.5XC-3, Olympus; Hamburg, Germany) (total magnification: 5×). Image stacks were then analyzed in ImageJ (NIH; Bethesda, USA) with an open-source CASA program (Giaretta et al., 2017; Wilson-Leedy & Ingermann, 2006) adapted for human sperm.
Hyperactivation of non-capacitated swim-up sperm (1 × 106 cells/ml) prepared in HTF0BC was measured by supplementing HSA (3 mg/ml) only immediately prior to the experiment to prevent attaching of sperm to the surface of the recording chamber. Hyperactivation of capacitated swim-up sperm was studied following incubation of sperm for at least 3 h under capacitating conditions in HTF++. The sperm sample was diluted to 1 × 106 cells/ml in HTF++ before transferring to the recording chamber. Sperm with a curvilinear velocity (VCL) ≥ 150 µm/s, linearity (LIN) ≤ 0.5, and amplitude of lateral head displacement (ALH) ≥ 7 µm were classified as hyperactive (Mortimer et al., 1998).
Microfluidic rapid-mixing CASA
Progesterone-evoked motility changes in swim-up sperm were measured with the inverted IX73 microscope and incubator setup used for single-cell Ca2 fluorimetry, equipped with the 0.5× magnification adapter and 10× objective used for standard CASA analysis. A microfluidic chamber with three inlets (µ-Slide III 3in1, Ibidi; Gräfelfing, Germany) was connected via 3/2-way valves to the following reservoirs: (1) capacitated sperm (5 × 106 cells/ml HTF++), (2) HTF++, and (3) HTF++ containing progesterone (10 µM). The single outlet of the chamber was connected to a syringe pump (World Precision Instruments; Sarasota, USA), which, by setting the 3/2-way valves, pulled fluid from two designated reservoirs (e.g., sperm and HTF++ (control) or sperm and HTF++ containing progesterone) under laminar flow, priming the chamber for mixing. By abruptly reversing the pump, the laminar fluid layers inside the chamber were turbulently mixed. Time-stamped dark-field images (80 fps) were continuously recorded over 180 seconds with the CMOS camera (80 fps) also used for standard CASA. Three one-second image sequences were extracted from the following time frames for analysis with the ImageJ-based CASA program as described before: 0–15, 16–30, 31–45, 46–60, 61–75, 105–120, and 165–180 seconds. The CASA results of the respective time frames were pooled to calculate the overall percentage of hyperactivated sperm.
Flagellar-beat analysis of head-tethered sperm
The basal flagellar waveform of head-tethered swim-up sperm was analyzed using the IX73 microscope, condenser, and dark-field filter setup also used for single-cell Ca2+ fluorimetry, equipped with a 20× objective (UPLFLN20XPH, Olympus; Hamburg, Germany). Dark-field image sequences (250 fps, 5 sec) of single spermatozoa were recorded using a sCMOS camera (Zyla 4.2 Plus, Andor Technology; Belfast, UK) and analyzed in ImageJ using the software tool ”SpermQ” (Hansen et al., 2018); https://github.com/hansenjn/SpermQ. To measure progesterone-evoked motility responses, sperm suspension was fortified with 2 µM caged-progesterone (Kilic et al., 2009). Head tethered sperm were recorded (135 fps) 15 seconds before and after photo-release (2 sillumination at 365 nm) of progesterone from the caged-progesterone.
Asymmetry Index
The maximal beat amplitude along the arc length of the flagellum both above and below the head-midpiece axis of the sperm was measured to determine the beat envelope. The “asymmetry index” was calculated by taking the ratio of the area under the beat envelope, i.e. area under the curve (AUC), generated by the beat envelope above (↑AUC) and below (↓AUC) the head-midpiece axis, respectively, according to the following equation:
Hence, an asymmetry index of 0 indicates perfect beat symmetry, while a value of 1 indicates complete asymmetry. The asymmetry index was measured before and after the photo-release of progesterone from the caged progesterone.
Viscous media penetration test
Capillary tubes (0.2 × 4.0 mm) (VitroTubes, VitroCom; Mountain Lakes, USA) were filled by capillary action with HTF++ supplemented with 1% w/v methyl cellulose containing either progesterone (3 µM) or vehicle (DMSO) and capped with sealing wax (Glaswarenfabrik Karl Hecht; Sondheim vor der Rhön, Germany). Swim-up sperm were capacitated in HTF++ in aliquots of 300 µl at 3 × 106 cells/ml. After adding either progesterone (3 µM) or vehicle (DMSO), the filled capillary tubes with the corresponding content were placed upright in these sperm suspensions, and placed in an incubator (37 °C, 10% CO2). After one hour, sperm within a field-of-view corresponding to 600 µm above and below the 2-cm mark inside the capillary were counted, and the fraction of motile sperm in the suspension was determined using the upright BX-40 microscope. The number of cells at the 2-cm mark was normalized to the fraction of motile sperm, correcting for inter-sample variation.
Acrosome Reaction
The evaluation of the acrosome reaction was performed based on a slightly modified protocol previously described (Rennhack et al., 2018; Tamburrino et al., 2014). Briefly, capacitated swim-up sperm in HTF++ (2 × 106 cells/ml) were incubated with either progesterone (5 µM) or ionomycin (5 µM) for 1 h at 37 °C, or supplemented with the equivalent volume of HTF++ (control). Afterwards, sperm were washed by centrifugation (700 × g, 5 min, room temperature) and resuspended in a hypo-osmotic swelling medium (1:10 HTF++:ddH2O) for 1h at 37°C. After a second washing step, sperm were fixed in 50 μl of ice-cold methanol, transferred on a slide in five aliquots (10 μl per spot), air-dried, and stored at −20 °C. For acrosome staining, the fixed sperm were thawed and incubated with 1 mg/ml FITC-labelled Arachis hypogaea (peanut) agglutinin (PNA) lectin (Sigma Aldrich; Steinheim, Germany) in PBS at 4 °C for 20 min in the dark. Slides were washed with PBS and incubated for 10 s with 5 mg/ml DAPI (ThermoFischer; Waltham, USA) in ddH2O at room temperature, washed again with PBS, and air dried. Images from the slides were taken using an AXIO Observer microscope (Carl Zeiss; Jena, Germany). For each condition, 200 curled-tail (viable) sperm were considered for analysis. Acrosomal status was assessed manually in a blinded fashion by two independent operators using a custom-designed counting aid software. The results of the two independent assessments were averaged.
Data analysis
Experiments and data analysis were performed without randomization and blinding, except for the acrosome reaction test. All data is presented as mean ± standard deviation (SD), unless otherwise stated. Statistical analysis was performed using GraphPad Prism 5 (GraphPad Software; San Diego, USA). If the experiment involved two conditions (control and treatment), a two-tailed paired t-test was used. Results from donors and CatSper-deficient patients obtained under the same conditions were also analyzed using two-tailed unpaired t-test. ANOVA was used for experiments involving one parameter measured over time (repeated measures with Dunnett’s multiple comparisons post hoc test) or more than one treatment (one-way with Bonferroni’s multiple comparisons post hoc test).
Results
A simple motility-based test allows to determine the activity of CatSper in human sperm
To elucidate the role of CatSper in male-factor infertility, we set out to develop a simple laboratory test that identifies patients with defective CatSper function. Lowering the extracellular Ca2+ concentration ([Ca2+]o) to nanomolar levels renders mouse (Jin et al., 2007) and human sperm (Schiffer et al., 2020; Torres-Flores et al., 2011) immotile. In CatSper-deficient mouse sperm, the cessation of motility by low [Ca2+]o is abolished (Jin et al., 2007), demonstrating that it requires functional CatSper. We tested whether this holds true for human sperm. An aliquot of the ejaculate from donors with normal CatSper function was diluted tenfold with control (HTF+) or Ca2+-free HTF buffer (HTF0Ca, [Ca2+]o < 20 nM), and the ensuing change in the fraction of motile sperm was monitored over time. In control buffer, the fraction of motile sperm remained constant, whereas in Ca2+-free buffer, it decreased exponentially with a time constant (τ) of 27 ± 11 min (mean ± standard deviation (SD), n = 9) (Fig. 1A). In Ca2+-free buffer fortified with the CatSper-inhibitor RU1968 (Rennhack et al., 2018), the decrease was abolished (Fig. 1A), indicating that it requires functional CatSper. Of note, in human sperm, CatSper is activated by steroids and prostaglandins contained in reproductive fluids (Brenker et al., 2018b; Jeschke et al., 2021; Lishko et al., 2011; Strünker et al., 2011), and whereas inhibition of CatSper abolished the motility decrease in Ca2+-free buffer, it was accelerated about fourfold upon activation of the channel by progesterone (Fig. 1A). We surmised that the action of low [Ca2+]o on human sperm motility can be harnessed to assess the activity of CatSper by an end-point motility test.
(A) Changes in the fraction of motile sperm (mean ± SD) upon dilution of semen samples from donors in Ca2+-free HTF (HTF0Ca) (diamonds), HTF0Ca containing progesterone (10 µM) (triangles), or HTF0Ca containing the CatSper-inhibitor RU1968 (15 µM) (squares), relative to the fraction of motile sperm determined upon dilution of the respective semen sample in control HTF+ (circles) at t = 0 (set to 100%). An exponential decay curve was fitted to the change in the fraction of motile cells averaged over all replicates. (B) Left: CatSper-Activity-Indices (CAI, see explanation in the text) determined 15 minutes after dilution of semen samples from donors in HTF+ (Buffer A) and HTF0Ca containing progesterone (triangles) (Buffer B) or Buffer B also containing RU1968 (15 µM) (squares). Right: CAI values from semen samples of men undergoing semen analysis (n = 2,286); see explanation in the text as to the dotted line. Patients with confirmed loss or impaired CatSper function are labeled C1-C9 and indicated with a color-coded circle. (C) Representative Ca2+ signals in sperm from patient C1-C9 (color coded) and a donor (black) evoked by progesterone (3 µM), PGE1 (3 µM), or NH4Cl (30 mM) relative to the maximal signal amplitude evoked by ionomycin (3 µM) (set to 1). (D) Mean (± SD) maximal Ca2+-signal amplitude in sperm from donors (black) and patients C1-C9 (color coded) evoked by progesterone (3 µM) (gray), PGE1 (3 µM) (orange), or NH4Cl (30 mm) (blue) relative to that evoked by ionomycin (set to 1). (E) Left: Representative whole-cell currents recorded from a donor sperm cell at pHi 7.3 in extracellular solution containing Mg2+ and Ca2+ (HS) and in Na+-based divalent-free bath solution (NaDVF). Currents were evoked by stepping the membrane voltage from -100 to +100 mV and +150 mV from a holding potential of -80 mV. Right: Representative currents recorded under the same conditions from a sperm cell from patient C6; the prototypical monovalent CatSper currents in NaVDF are abolished. (F) Steady-state current amplitudes at +100 mV and -100 mV in NaDVF recorded from sperm from donors (black) and patients C1-C8 (color coded). (G) Representative whole-cell currents recorded from patient C6 (black) and patient C9 (red) at pHi 7.3 in NaDVF. Currents were evoked by stepping the membrane voltage from -100 to +150 mV from a holding potential of -80 mV. (H) Steady-state current amplitudes at +150 mV and -100 mV in NaDVF recorded from sperm from patients C1-C8 (color coded) as shown in G (consider the different scales of Y-axes) compared to that recorded in sperm from patient C9 (light green). Replicates shown for patient C9 in (D) and (H) represent results from experiments performed independently on sperm from three different semen samples. Of note, data on Ca2+ responses and membrane currents in sperm from patient C1-C5 comprise data from Schiffer et al. (2020), reporting on these five patients for the first time, combined with data from additional experiments.
As a proof-of-concept, we diluted the ejaculate from donors with HTF+ (Buffer A) and HTF0Ca containing progesterone (Buffer B). After 15 minutes, the fractions of motile sperm in A and B were determined and a ‘CatSper-Activity-Index (CAI)’ was calculated 
, which ranged from 70–100; however, when Buffer B was fortified with RU1968, the CAI decreased to < 40 (Fig. 1B, left), reflecting that inhibition of CatSper rescues sperm motility in Buffer B. These results supported the notion that this motility-based test, which we refer to as the CatSper-Activity-Test, allows to systematically assess the activity of CatSper in human sperm.
The CatSper-Activity-Test identifies patients with defective CatSper function
We next performed the CatSper-Activity-Test over a period of three years on 2,286 men undergoing semen analysis in the course of a fertility workup. In more than 99%, the CAI was > 40 (Fig. 1B, right), which we regarded as indicative of rather normal CatSper function; prototypical CatSper-mediated Ca2+ signals recorded in sperm from a representative sample of 48 of those men supported this assumption (not shown). In 16 men subjected to the CatSper-Activity-Test, the CAI was however similar to that in donors upon inhibition of CatSper, i.e., ≤ 40, indicative of defective CatSper function (Fig. 1B, right). A series of follow-up experiments confirmed that nine of these men – in the following referred to as patients C1–C9 (Fig. 1B, right, color-coded circles) – indeed featured defective CatSper function. Sperm isolated from ejaculates of patients C1–C8 lacked the prototypical Ca2+ signals evoked by progesterone-, prostaglandin E1-, or alkaline-activation of CatSper in sperm populations (Fig. 1C, D, colored traces and circles); the Ca2+ signal evoked by the Ca2+ ionophore ionomycin was however preserved. For patients C1 and C2, the lack of CatSper-mediated Ca2+ signals was validated on the single-cell level (Supplementary Fig. 1). Electrophysiological recordings revealed that sperm from patients C1-C8 also lacked CatSper-mediated membrane currents (Fig. 1E, F). Furthermore, in sperm from patient C9 (Fig. 1B, green circle), CatSper-mediated Ca2+ signals (Fig. 1C, D, green trace and circles, respectively) were 5- to 10-fold reduced in amplitude and featured an atypical mono-rather than biphasic waveform (Fig. 1C); CatSper-mediated membrane currents were also largely, but not entirely, abolished (Fig. 1G, H). Thus, whereas sperm from patients C1–C8 lacked functional CatSper channels, patient C9 featured a severely impaired CatSper function. These results demonstrate that a fraction of men undergoing a fertility workup suffers from defective CatSper function, which can readily be identified by the CatSper-Activity-Test.
Of note, as detailed in Supplementary Fig. 2, we successively optimized the CatSper-Activity-Test during the course of screening to minimize and, finally, avoid false positive results. Moreover, using ejaculates from donors and CatSper-deficient patients as a tool, we revealed that the test distinguishes best between men with normal versus loss of CatSper function when the fraction of motile sperm is determined 60 min after dilution in the test buffers. However, additional studies are required to determine the test’s sensitivity and specificity using the optimized conditions.
Defective CatSper function is linked to germline mutations in CATSPER genes
Genetic workup elucidated the pathomechanisms underlying the defective CatSper function: Patients C1–C8 shared a homozygous deletion of the CATSPER2 gene located on chromosome 15 (Fig. 2A, Supplementary Fig. 3, Supplementary Table 3). In patients C1–C5, the deletions were similar on both homologues chromosomes and involved, except for patient C5, also the homozygous deletion of the CKMT1B and STRC genes (Fig. 2A, Supplementary Fig. 3). In patients C6–C8, the homologous chromosomes exhibited distinct deletions, resulting in heterozygous deletion of STRC and CKMT1B (Fig. 2A, Supplementary Fig. 3). Of note, patient C1 and C2 are brothers, and their parents as well as another brother are heterozygous carriers of the deletion, whereas their sister is homozygous (Fig 2C).
(A) Schematic depiction of chromosome 15, magnified region q15.3 including genes, and the identified deletions (represented as filled color-coded bars) in patients C1-C8, but not patient C9. All positions according to hg19/GRCh37. (B) Schematic depiction of chromosome1, magnified region q44 and compound-heterozygous variants (see panel D) (c.536G>A and c.2394_2399del) of CATSPERE (NM_001130957.2) identified in patient C9. (C) Family pedigree of patients C1 and C2, who are brothers. Their sister is also homozygous for the deletion at 15q15.3, whereas their mother, father, and third brother are heterozygous carriers. (D) Family pedigree of patient C9, demonstrating that the father and mother are carriers of the missense variant (c.536G>A) and in-frame deletion (c.2394_2399del), respectively. Of note, in Schiffer et al. (2020), we already showed array-CGH data from patients C1-C5, reporting on the deletion of CATSPER2 in these five patients for the first time.
Patient C9 carried the compound-heterozygous nucleotide variants c.536G>A and c.2394_2399del in the CATSPERE gene (NM_001130957.2) located on chromosome 1 (Fig. 2B) inherited from the father and mother, respectively (Fig. 2D). The according to gnomAD novel c.536G>A variant causes a possibly deleterious amino acid substitution p.(Gly179Glu) (CADD score = 25.7). The variant c.2394-2399del causes an in-frame deletion of two amino acids p.Met799_Ala800del, features an allele frequency of 0.001183 (gnomAD), and has already been described in association with CatSper-related male infertility (Brown et al., 2018; Williams et al., 2015).
In summary, homozygous deletion of CATSPER2 (CATSPER2-/-) underlies the loss of CatSper function in patients C1-C8. The severely impaired CatSper function in patient C9 is almost certainly due to the compound-heterozygous variants in CATSPERE.
CATSPER2-/- patients are normozoospermic, but infertile, and require ICSI to father a child
Next, we assessed the clinical phenotype of the patients. Patients C1-C7 were normozoospermic, i.e., sperm number, motility, and morphology were within reference limits (Table 1, Supplementary Movie 1), demonstrating that deletion of CATSPER2 and loss of CatSper function do not affect the production of sperm. In patients C8 and C9, sperm number and motility were also within reference limits, but both featured mild teratozoospermia.
Patients C1–C6 and C8 presented with unexplained couple infertility, and in patients C1–C6, not only natural conception, but also medically-assisted reproduction via OI, IUI, and/or IVF failed (Table 1). For patient C5, an IVF/ICSI attempt was documented by video microscopy. Ten minutes after joining the gametes, sperm were already found bound to the oocytes’ surfaces, which after 24 hours, were enveloped by sperm (Fig. 3A, Supplementary Movie 2). However, none of the five oocytes subjected to IVF were fertilized (Fig. 3A), indicating that the sperm failed to penetrate the zona pellucida. Supporting this notion, ICSI performed on 15 oocytes in parallel to the IVF yielded nine embryos (Fig. 3B), corresponding to a fertilization rate of 60%. Similarly, in patients C1–C4, C6, and C8, fertilization was only achieved by ICSI also resulting in live births (Table 1). Finally, patients C7 and C9 were childless, but did not present due to suspected infertility; the identification of the defective CatSper function as well as the underlying genetic aberrations came as incidental findings. Altogether, these results demonstrate that loss of CatSper function results in, according to standard fertility workup, unexplained infertility involving OI, IUI, and IVF failure.
(A) Left: Representative micrograph of an oocyte with CATSPER2-/- sperm from patient C5 attached to thezona pellucida (indicated by arrows in the zoomed-in image, middle), taken after overnight incubation of sperm and oocyte for in-vitro fertilization (IVF). None of the five oocytes subjected to IVF was fertilized (right, representative example). (B) Left: Representative micrograph of an oocyte with an inserted glass pipette containing a CATSPER2-/- sperm cell form patient C5 (indicated in the zoomed-in image, middle) for intracytoplasmic sperm injection (ICSI). Nine out of the 15 eggs injected with CATSPER2-/- sperm developed two pronuclei (right, representative example) indicating fertilization. Scale bars represent 30 µm.
Stratification of the men enrolled in our study (Supplementary Fig. 4) revealed that 1.2% of normozoospermic men presenting with couple infertility featured a defective CatSper function. Assuming that in half of the infertile couples including a normozoospermic men, the infertility is rather due to a female factor, we can estimate a prevalence of 2.3% for CatSper-related male-factor infertility among couples presenting with unexplained infertility (Supplementary Fig. 4).
We further examined whether patients lacking both CATSPER2 and STRC (STRC-/-) exhibited sensorineural deafness. Standard audiometry indeed revealed a mild-to-moderate hearing impairment in patients C1–C4 (Supplementary Fig. 6), confirming that they suffer from the deafness-infertility syndrome. Of note, the cause of their hearing impairment was not known to the patients before. This is not surprising: although it is well-known that variants in STRC represent the second most common genetic aberration causing mild-to-moderate hearing loss (prevalence ∼4%) (Yokota et al., 2019), the gene is still not routinely assessed in the genetic workup of hearing impairment. Therefore, deletions of STRC and, thus, also the deafness-infertility syndrome are largely underdiagnosed. Expectedly, in patient C5 with unaffected STRC and patient C7 with a heterozygous deletion of STRC (STRC+/-), the audiogram was within normal limits (Supplementary Fig. 6). For STRC-/+ patients C6 and C8, we did not obtain an audiogram, but neither patient reported impaired hearing.
Loss of CatSper function affects sperm hyperactivation and migration in viscous media
Next, we set out to unravel the pathomechanism underlying the infertility of CATSPER2-/- patients and the failure of OI, IUI, and IVF. To this end, we investigated the motility of their sperm both in population and on the single cell level. First, we diluted the ejaculate of donors (control) and patients with HTF+ and quantified the basal motility parameters of sperm in population by standard computer-assisted sperm analysis (CASA) (Fig. 4A). The individual motility parameters were largely similar in CATSPER2-/- and control sperm (Fig. 4B), rendering defective CatSper function rather undetectable by CASA. However, when averaged over all donors and patients, beat-cross frequency (BCF; reflecting the beat frequency) and indicators of the linearity of the swimming path (i.e., LIN, STRC) were slightly enhanced in CATSPER2-/- sperm (Fig. 4B). Thus, sperm lacking functional CatSper tend to swim with a slightly higher beat frequency and somewhat straighter. Next, we isolated via the swim-up technique non-capacitated, motile sperm from the ejaculate of donors and CATSPER2-/- patients, tethered them with their head to the surface of a recording chamber, and analyzed the flagellar beat of individual sperm using the SpermQ software (Hansen et al., 2018) (Fig. 4C–E). Compared to control sperm, CATSPER2-/- sperm beat with slightly higher frequency and reduced amplitude (Fig. 4C–E), matching the outcome of CASA. These minor anomalies, however, do not explain the infertility and IUI/IVF failure, but rather demonstrate that CatSper does not play a critical role in the control of basal motility features (Luo et al., 2019; Wang et al., 2021b; Williams et al., 2015). Supporting this notion, in a previous study using motile sperm isolated from the ejaculate of some of the CATSPER2-/- patients characterized in detail herein, we showed that loss of CatSper function does not affect rotational motion and rheotaxis either (Schiffer et al., 2020).
(A) Illustration of the swimming path and kinematic parameters of a sperm cell determined by computer-assisted sperm analysis (CASA). Curvilinear velocity (VCL) represents the frame-to-frame track of the sperm head, from which the average-path velocity (VAP) is calculated. The beat-cross frequency (BCF) is the frequency at which the sperm track crosses the VAP path. The amplitude of lateral head displacement (ALH) is the average deviation of the head from the VAP path. The straight-line velocity (VSL) is derived by charting a direct path between the first and last head position in the image sequence. The linearity (LIN), straightness (STR), and wobble (WOB) are indicators for the linearity of the path trajectory. (B) Scatter plots (mean ± SD) of kinematic parameters of control (black triangles, n = 22) and CATSPER2-/- sperm from patients C1-C8 (color-coded circles). (C) Scatter plots (mean ± SD) of the flagellar beat frequency of single head-tethered control sperm from donors (black triangles, n = 29 from six experiments) and of sperm from CATSPER2-/- patients (color-coded circles, n = 30 from three experiments). (D) Maximal beat amplitude (mean ± SD) along the arc length of the flagellum of the head-tethered control (black) and CATSPER2-/- (red) sperm analyzed in (C). (E) Scatter plots (mean ± SD) of the maximal beat amplitude of the control (black triangles) and CATSPER2-/- (color-coded circles) sperm reported on in (C) and (D). *P < 0.05, **P < 0.01, ***P < 0.001, unpaired t-test with Welch’s correction.
However, to penetrate the zona pellucida and fertilize the oocyte, sperm must switch to hyperactivated motility, a powerful flagellar beat characterized by high asymmetry and low frequency resulting in a tortuous swimming trajectory (Suarez, 2008). The role of CatSper in human sperm hyperactivation has remained controversial (Brown et al., 2019; Wang et al., 2021a). We first determined whether spontaneous hyperactivation that develops during capacitation – a maturation process of sperm inside the female genital tract – is impaired or even abolished in CATSPER2-/- sperm. To this end, we incubated motile sperm under capacitating conditions in HTF++ and determined the fraction of hyperactive sperm by CASA. In donors, the fraction of hyperactive sperm was 12.2 ± 6.1% (n = 17), whereas it was only 0.8 ± 1.0% (n = 10) in CATSPER2-/- patients (Fig. 5A), demonstrating that loss of CatSper function abolishes spontaneous capacitation-induced hyperactivation (for more details, see Supplementary Fig. 6). We next studied the action of progesterone on the swimming behavior and flagellar beat of capacitated control and CATSPER2-/- sperm using microfluidics- and optochemistry-aided motility and flagellar-beat analyses. In fact, whether progesterone evokes hyperactivation and whether this can be detected by CASA have been long-standing controversial issues (Baldi et al., 2009; Brown et al., 2019). Indeed, when determined five minutes after stimulation, progesterone did not significantly increase the fraction of hyperactive sperm (Fig. 5B). Considering the transient nature of progesterone-induced Ca2+ signals (see Fig. 1C), we surmised that progesterone-evoked motility responses might also be rather transient. Therefore, we combined CASA with microfluidics to study changes in sperm motility in a time-resolved fashion (for more details, see Supplementary Fig. 7). Mixing of control sperm from donors with progesterone evoked a rapid, transient rise in hyperactivation: Within 15 seconds, the fraction of hyperactive sperm increased by 9.4 ± 5.3% (n = 5) and then declined again within 120 seconds to basal levels (Fig. 5C). This time course indeed resembles that of progesterone-induced Ca2+ responses (Fig. 1C). In CATSPER2-/- sperm, the progesterone-evoked hyperactivation was abolished (Fig. 5C), demonstrating that functional CatSper is required.
(A) Scatter plot (mean ± SD) of the fraction of hyperactivated control (black triangles, n = 17) and CATSPER2-/- sperm (color-coded circles, n = 10 experiments with sperm form patients C1, C2, C5, C7, and C8) upon incubation under capacitating conditions. (B) Paired plots of the fraction of hyperactivated control sperm from donors before (basal) and after treatment (5 min) with progesterone (5 µM) determined by standard CASA. (C) Change of the fraction (mean ± SD) of hyperactivated control sperm from donors (black, n = 5) and from a CATSPER2-/- patient (blue, n = 3, i.e., three independent experiments with sperm form patient C5) evoked by mixing with progesterone (gray bar), corrected for the fraction of hyperactivated sperm determined after mixing with HTF++ alone (set to 0 at t = 0 s), and determined by a custom kinetic CASA technique. Experiments were performed with sperm incubated under capacitating conditions. **P < 0.01, ***P < 0.001, ANOVA with Dunnett’s multiple comparison test versus the respective controls (t = 0 s).
To scrutinize this finding by an independent technique, we studied the action of progesterone on the flagellar beat of individual capacitated head-tethered sperm. To this end, we bathed the sperm in HTF++ fortified with caged progesterone (Kilic et al., 2009; Rennhack et al., 2018) and analyzed their motility and flagellar beat before and after uncaging progesterone with a brief UV flash. In general, for head-tethered sperm, the flagellar beat and its inherent asymmetry results in an oscillatory rotational motion around the point of attachment (Fig. 6A, B) (Saggiorato et al., 2017; Schiffer et al., 2014). We determined the rotation velocity (Fig. 6A, B, upper panels) as well as the frequency and amplitude of the oscillation (Fig. 6A, B, lower panels) in control and CATSPER2-/- sperm before and after uncaging progesterone (see also Supplementary Movie 3 and 4). Before uncaging progesterone, the CATSPER2-/- sperm featured a slightly, but statistically insignificant, enhanced beat frequency and reduced beat amplitude compared to control sperm, whereas the rotation velocity was similar (Fig. 6B, Supplementary Fig. 8). In control sperm, uncaging progesterone decreased the beat frequency by 3.1 ± 1.5 Hz (n = 9), whereas the beat amplitude and rotation velocity increased by 4.9 ± 7.4° and 95 ± 69°·s-1 (n = 9), respectively, suggesting a switch to hyperactive motility (Fig. 6B, Supplementary Fig. 8, Supplementary Movie 3). In CATSPER2-/-sperm, progesterone did not affect these motility parameters (Fig. 6B, Supplementary Fig. 8, Supplementary Movie 4).
(A) Representative time-lapse overlays of three beat cycles before and after uncaging progesterone (2 µM) of a pivoting head-tethered capacitated control sperm from a donor. (B) Change of angle θ over time (solid line, upper panels) with the corresponding slope (dotted line) and fitted sine wave of the oscillation (lower panels) of control (black, left panel) and CATSPER2-/- (gold, right panel) sperm from patient C1 before and after uncaging progesterone. The corresponding frequency and amplitude of the flagellar beat were derived from the fitted sine wave and the rotation velocity, Ω(°·s-1) was derived by the slope of the change of θ over time. (C) Representative overlays of a single beat cycle of a control (cyan) and a CATSPER2-/- (gold) sperm before and after the uncaging of progesterone (2 µM). (D) The area under the curve outlined by the beat envelope above (↑AUC) and below (↓AUC) the head-midpiece axis of a control sperm before (left panel) and after (right panel) the photo-release of caged progesterone used to derive an asymmetry index (for more details, see material and methods). (E) Paired plot depicting the corresponding asymmetry index of the flagellar beat in (D). (F) The asymmetry index (mean ± SD) of the basal flagellar beat of control (black, n = 8, two donors) and CATSPER2-/-(gold, n = 8, patient C1) sperm prior to progesterone exposure. (G) The change in the asymmetry index (mean ± SD) relative to the asymmetry index immediately prior (set to 0 at the mean of t = -10 s and 0 s) to the photo-release of progesterone of control (black triangles) and CATSPER2-/- (gold circles) sperm described in (F). ***P < 0.001, ANOVA with Dunnett’s multiple comparison test versus the respective controls (t = 0 s).
To determine whether progesterone affects also the asymmetry of the flagellar beat, we superimposed images of individual head-tethered sperm recorded during one beat cycle and analyzed these quasi stop-motion images (Fig. 6C). Before uncaging, both control (Fig. 6C, cyan) and CATSPER2-/- (Fig. 6C, gold) sperm beat largely symmetric. In control, but not in CATSPER-/- sperm, uncaging progesterone induced an increase in beat amplitude and a highly asymmetrical, whip-like beating pattern – hallmarks of hyperactive motility (Fig. 6C). The changes in beat asymmetry were quantified by determining an ‘asymmetry index’ (Fig. 6D, E); asymmetry-index values of 0 and 1 indicate perfect beat symmetry and maximal asymmetry, respectively. Prior to uncaging progesterone, the asymmetry index was similarly low in control and CATSPER2-/- sperm (0.25 ± 0.11 versus 0.25 ± 0.11, n = 8) (Fig. 6F). Progesterone increased the asymmetry index in control sperm by about ∼2.5-fold (Fig. 6D, E, G), whereas in CATSPER2-/-sperm, if at all, it slightly decreased (Fig. 6G). Altogether, the motility and flagellar-beat analyses show that loss of CatSper function abolishes both spontaneous and progesterone-induced hyperactivation.
We also studied the migration of control and CATSPER2-/-sperm into viscous medium using a modified Kremer’s sperm-mucus penetration test. An open glass capillary containing HTF++ fortified with methylcellulose was partially submersed in a suspension of sperm incubated under capacitating conditions in HTF++ (Fig. 7A). In the absence of progesterone, the numbers of control and CATSPER2-/- sperm penetrating the viscous medium were similar (Fig. 7B), demonstrating that penetration into viscous medium per se does not require CatSper (Luo et al., 2019; Williams et al., 2015). In the presence of progesterone, the number of control sperm was enhanced by 1.7- fold (Fig. 7B, C), confirming that progesterone facilitates the migration into viscous medium (Brown et al., 2017; Luo et al., 2019; Rahban et al., 2021; Rehfeld et al., 2020; Williams et al., 2015). This action of progesterone was abolished in CATSPER2-/- sperm (Fig. 7B, C), demonstrating that it requires functional CatSper (Luo et al., 2019; Williams et al., 2015).
(A) Experimental layout of the viscous media penetration test. Glass capillaries are filled with a 1% w/v methyl cellulose solution in HTF++ fortified with either DMSO (vehicle) or progesterone (3 µM) and then placed in tubes containing capacitated sperm suspended in HTF++ fortified correspondingly with DMSO or progesterone. After one hour, the number of sperm reaching the 2-cm mark in each capillary were counted. (B) Paired plots of the number of control (black triangles, n = 10) and CATSPER2-/- sperm (color-coded circles, n = 10 from four independent experiments with sperm from patients C2, C5, C7) at a penetration distance of 2 cm in a modified Kremer’s sperm-mucus penetration using a capillary containing the vehicle (V) or progesterone (P; 3 µM). (C) Fold change in the number of control (black triangles) and CATSPER2-/- sperm (color-coded circles) at 2 cm in the presence of progesterone, relative to the vehicle (set to 1); ***P < 0.001, paired t-test.
To fertilize the egg, sperm must also undergo acrosomal exocytosis (Hirohashi & Yanagimachi, 2018). We studied acrosomal exocytosis using FITC-labelled pisum sativum agglutinin (FITC-PSA) as a marker (Fig. 8A). Spontaneous and ionomycin-induced acrosomal exocytosis was similar in control and CATSPER2-/- sperm (Fig. 8B), confirming that it is not per se affected by loss of CatSper function (Luo et al., 2019); see however (Wang et al., 2021b). To elucidate the role of Ca2+ influx via CatSper, we studied the action of progesterone, which in most (Harper et al., 2006; Krausz et al., 1996; Luo et al., 2019; Rahban et al., 2021; Rehfeld et al., 2020; Rennhack et al., 2018; Schaefer et al., 1998; Tamburrino et al., 2014) but not all (Prajapati et al., 2022; Uhler et al., 1992) previous studies sufficed as a physiological stimulus for acrosomal exocytosis and was abolished in sperm lacking functional CatSper (Luo et al., 2019). Under the experimental conditions used here, the fraction of acrosome reacted control sperm was not significantly enhanced by progesterone (Fig. 8B), which precluded scrutinizing the role of Ca2+-influx via CatSper for acrosomal exocytosis.
(A) Representative fluorescence images of capacitated control sperm from donors stained with DAPI (blue) and FITC-labelled peanut agglutinin (PNA) lectin that were considered non-acrosome reacted (non-AR) and acrosome reacted (AR). (B) Scatter plot of the fraction (mean ± SD) of acrosome-reacted control (black triangles, n = 5) and CATSPER2-/- sperm (color coded, n = 5) after incubation in HTF++ (basal; white), progesterone (5 µM; gray), or ionomycin (5 µM; yellow). Experiments were performed with sperm incubated under capacitating conditions. **P < 0.01, ANOVA with Dunnett’s multiple comparison test versus the respective basal value for control and CATSPER2-/- sperm.
Discussion
More than two decades ago, CatSper and its essential role in sperm function and male fertility in mice were discovered (Ren et al., 2001). Since then, the role of CatSper in spermatogenesis, sperm function, and male fertility in humans has remained ill-defined and controversial (Brown et al., 2019; Wang et al., 2021a). To clarify these long-standing issues, we developed the CatSper-Activity-Test, screened almost 2,300 subjects, identified a group of men with defective CatSper function, assessed their reproductive phenotype, and investigated the behavior of CatSper-deficient human sperm. This shows that CatSper is not required for sperm production in men. In fact, defective CatSper function is undetectable by state-of-the-art fertility workup based on standard semen and/or computer-based sperm analysis, but causes failure of medically assisted reproduction via OI, IUI and IVF (Luo et al., 2019; Wang et al., 2021b; Williams et al., 2015) – techniques of primary choice for couples presenting with unexplained infertility.
The infertility and need for ICSI can readily be explained by the failure of CatSper-deficient human sperm to hyperactivate spontaneously and upon hormone stimulation and, thus, to penetrate the zona pellucida on their own. Yet, loss of CatSper function also affects migration in viscous medium in vitro, which could prevent the sperm to even reach the site of fertilization in vivo. To this end, human sperm might also be instructed by long- and short-range cues to locate the oocyte by rheotaxis, thermotaxis, chemotaxis, or a combination thereof (Alvarez et al., 2014)). CatSper is not required for rheotaxis (Schiffer et al., 2020), but the role of CatSper in human sperm chemotaxis and thermotaxis remains to be elucidated. Thus, studies mimicking in vitro the complex chemical, topographical, and hydrodynamic landscapes of the female genital tract (Kirkman-Brown & Smith, 2011; Suarez, 2008; Suarez & Pacey, 2006) are required to gain further insights into the role of CatSper for sperm migration and navigation in vivo. Future studies are also required to understand the role of Ca2+ influx via CatSper for acrosomal exocytosis using, e.g., physiological combinations of ligands and/or intracellular alkalization, which is more efficacious than progesterone alone in stimulating Ca2+ influx via CatSper (Brenker et al., 2018a; Prajapati et al., 2022) and acrosomal exocytosis (Prajapati et al., 2022; Schaefer et al., 1998). Finally, whether impaired CatSper function like in patient C9 also affects sperm function and male fertility remains to be determined. To this end, it is required to identify more patients with impaired rather than loss of CatSper function, unravel if they can naturally conceive, and perform an in-depth analysis of the phenotype of their sperm. This might reveal the critical level of CatSper activity required for natural conception and IUI and/or IVF.
We further show that homozygous deletion of CATSPER2 is the main cause affecting CatSper function. Only in half of the CATSPER2-/-patients who we identified, STRC was also deleted, corresponding with the sensorineural hearing loss of affected patients. Our findings match with population genetics: Among the (likely) pathogenic variants identified in genes encoding CatSper subunits, deletion of CATSPER2 is by far the most common one with an allele frequency of about 1% each for deletion of CATSPER2 or CATSPER2 + STRC (gnomAD SVs 2.1). The high deletion frequency is most likely due to the architecture of the particular locus: The PPIP5K1, CKMT1, STRC, and CATSPER2 genes share > 98% sequence homology (Avidan et al., 2003) with their, except for CKMT1, pseudogenic counterparts created by segmental duplication (Fig. 2). This renders the genes prone to non-allelic homologous recombination (NAHR), resulting in sequence deletions, duplications, or inversions (Liu et al., 2012; Zhang et al., 2007). Of note, sperm from a man heterozygous for the deletion of CATSPER2 (CATSPER2+/-) featured CatSper-mediated membrane currents as well as basal motility parameters similar to that of control sperm from donors (Supplementary Fig. 9), supporting fully penetrant autosomal-recessive inheritance of CATSPER2-related infertility. The c.2394-2399del variant in CATSPERE of patient C9 has already been associated with CatSper-related male infertility (Brown et al., 2018; Williams et al., 2015) and features an allele frequency of 0.01%. The c.536G>A variant in CATSPERE as well as those previously described for CATSPER1 and CATSPER3 are much less frequent or even novel.
Furthermore, from the allele frequencies in the general population, we can deduce that the prevalence for defective CatSper function due to homozygous deletion of CATSPER2 is ∼0.01%, i.e., 1:10,000 men should be affected. In the group of men enrolled in our study, however, the prevalence was orders of magnitudes higher (Supplementary Fig. 4). This enrichment is to be expected, considering that we selected for men with fertility disorders. Nevertheless, even among the 500 men that presented for other reasons, we identified by chance two with defective CatSper function. Similarly, because of the frequent concomitant deletion of STRC, the prevalence for homozygous deletion of CATSPER2 is three orders of magnitude higher in men with mild-to-moderate hearing loss than predicted for the general population (Han et al., 2021; Yokota et al., 2019).
Because CatSper-related male infertility is undetectable by standard semen analysis, affected couples experience failed OI, IUI, and IVF treatments (Table 1). This is highly frustrating, time-consuming, expensive, and, most importantly, involves repeated treatment of the female. Thus, early diagnosis of CatSper-related male-factor infertility enables an evidence-based selection of the technique for medically assisted reproduction, shortening the time towards reproductive success for affected couples, reducing both psychological burdens and expenses, and minimizing the medical risk for the female. Given its simplicity and benefit, we envision the CatSper-Activity-Test be performed along with standard semen analysis to identify patients with defective CatSper function. Importantly, its readout reveals defective CatSper function irrespective of the underlying genetic or non-genetic pathomechanism. In fact, such transfer of basic knowledge into the clinics, undoubtedly improving both diagnostic and care of patients, has been lacking in the field of male infertility. Our study might, thus, serve as a blueprint for future studies unraveling the mechanisms underlying seemingly unexplained infertility and developing novel diagnostic tools.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Author contributions
C.Br., C.S., and T.S. conceived the project. S.Y., C.S., C.Br., F.T., and T.S designed the research and interpreted the results. S.Y., C.S., A.W., J. P., A.R., M.K., C. Bi., L.He., B.S., A.R., T.W., L.Ha., D.D., C.Br., and T.S. performed experiments and analyzed the data. V.N., T.P., C.K., J. N.H., D.W., B.R., H.M.B, S.S. and S.K. contributed to the design of research and/or analysis and interpretation of results. C.K., S.K. and F.T. recruited the men enrolled in the study. C.K., V.N., T.P., A.R., H.M.B., S.K., and F.T. performed the genetic and clinical workup and treatment of patients/couples. S.Y. and T.S. wrote the manuscript. C.S., C.Br., and F.T. contributed to the writing of the manuscript. All authors revised the manuscript critically for important intellectual content and approved the manuscript.
Conflict of Interest
S.Y., C.S., C.Br., and T.S. are inventors on a patent application filed by the University of Münster, Germany, related to CatSper-Activity-Test presented in this paper and co-founders of a company that further develops the test. All other authors declare no competing interests.
Acknowledgements
We thank all present and former members of the Andrological Laboratory of our center as well as the donors and patients for supporting this study. B.R., D.W., S.K., S.S., F.T., C.B. and T.S. are supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - project numbers 329621271 (CRU326; B.R., S.K., S.S., F.T., C.B., T.S,), 420653497 (CRC1450; B.R.), 432325352 (SFB1454; D.W.), 450149205 (TRR333/1; D.W.), and 390873048 (EXC2151; D.W.). D.W. is also supported by the Else-Kröner-Fresenius Foundation (2021.EKFSE.53) and intramural funding from the University of Bonn, T.S. by the Interdisciplinary Center for Clinical Research Münster (IZKF; Str/014/21) and the Europäischer Fonds für regionale Entwicklung (EFRE; 0400305), C.B. by the “Innovative Medical Research” of the University of Münster Medical School (IMF; BR 121507), and S.Y/C.S by the EXIST program of the Federal Ministry of Economic Affairs and Climate Action and European (Europäischer Sozialfonds; 03EFQNW261).
References
